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T-cell intracellular antigen and proliferation <p>The transcriptome of TIA-1/TIAR-depleted cells indicates roles in inflammation, cell-cell signaling, immune suppression, angiogen- esis, metabolism and cell proliferation.</p>
Abstract
Background: T-cell intracellular antigen-1 (TIA-1) and TIA-1 related/like protein (TIAR/TIAL1),
two DNA/RNA binding proteins broadly expressed in eukaryotic cells, participate in the regulation
of gene expression through RNA metabolism. Despite the biological relevance of these regulators,
there are no genome-wide studies assessing global transcriptomic and phenotypic impacts after
changes in the expression and/or function of these proteins.
Results: Using high-throughput gene expression profiling, we found that the TIA-1/TIAR-depleted
cell phenotype is linked to a transcriptome involved in the control of inflammation, cell-cell
signaling, immune-suppression, angiogenesis, metabolism and cell proliferation. Induced genes
included pro-inflammatory cytokines, inflammatory chemokines, growth-stimulating factors and
pro-angiogenic inducers. Repressed genes involved the RAS oncogene family member RAB40B,
regulators of cytoskeleton organization and biogenesis and a mitochondrial modulator. Consistent
with these observations, depletion of TIA proteins in HeLa cells results in increased cell
proliferation, altered cell-cycle and anchorage-independent growth. Mechanistically, the changes
associated with the steady-state target mRNA levels regulated by TIA proteins are consistent with
overlapping effects on gene basal transcription rate and mRNA turnover.
Conclusions: Collectively, our findings suggest a role for TIA proteins as cellular sensors that
modulate gene expression control at the transcriptional and post-transcriptional levels, coupling
cell proliferation responses and metabolic homeostasis to cell survival and growth.
Background
One of the most important challenges resulting from our
knowledge of the human genome -  a n d ,  i n  g e n e r a l ,  o f  a l l
genomes - is to understand how the collection of RNAs and
proteins that define us as an organism are generated. Nowa-
days, we accept that the origin of our transcriptomic and pro-
teomic diversity is due not just to the number of genes present
in our genome but also to the dynamic and differential regu-
lation of their expression. The characterization of transcrip-
tional and post-transcriptional events leading to the
generation of multiple RNAs, proteins and functions from a
single or distinct RNA precursors reveals the existence of
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multiple layers and networks involved in regulating the
diverse biological functions controlled by the transcriptome
[1].
T-cell intracellular antigen (TIA)-1 and TIA-1 related/like fac-
tor (TIAR/TIAL1) are two proteins that play important roles
in many aspects of RNA biology, from RNA transcription to
splicing, stability and translation. Indeed, TIA proteins have
been shown to interact with RNA polymerase II [2], DNA
[3,4] and RNA [5] and to participate in the control of alterna-
tive pre-mRNA splicing [6-8]. TIA proteins bind to uridine-
rich sequences, which are mostly located in the introns, and
seem to facilitate the recruitment of U1 small nuclear ribonu-
cleoprotein, thus promoting the recognition and processing
of atypical 5' splice sites [9,10]. The cytoplasmic pool of these
proteins has been linked to the control of translation and/or
stability of some mRNAs through binding to adenine- and
uridine-rich sequences located in 3' untranslated regions [11-
14]. Additionally, these proteins are involved in cell responses
to metabolic and genotoxic stresses as well as the formation
of stress granules [15,16]. It has also been reported that these
proteins play a relevant role in the control of cell death [17-19]
and viral replication [20]. In fact, mice that lack either TIA-1
or TIAR show high rates of embryonic lethality, indicating a
relevant role for these proteins during embryonic develop-
ment [12,21]. Furthermore, recent studies have identified a
set of mRNAs that interact and are regulated by these pro-
teins [22-24].
Altogether, these findings strongly support a key role for TIA-
1 and TIAR proteins in the control of different aspects of RNA
metabolism and function. However, little is known about how
these regulators control the transcriptome and about the spe-
cific and/or overlapping functions associated with TIA pro-
teins at this level. Here, we use a loss-of-function approach
combined with global mRNA expression pattern and pheno-
typic profiling analyses to identify targets and pathways reg-
ulated by TIA proteins. Our data suggest that these proteins
are involved in the transcriptional and post-transcriptional
regulation of specific transcripts associated with the control
of key cellular functions, such as inflammation, cell prolifera-
tion and anchorage-independent growth responses.
Results
Gene expression profiling of TIA-1 and TIAR-depleted 
HeLa cells
To study the role of TIA-1 and TIAR in the global control of
gene expression, we transfected HeLa cells with double-
stranded small interfering RNAs (siRNAs) targeting TIA-1
and/or TIAR mRNAs or with control siRNA (c) as previously
described [10,25-27]. The effect of the siRNAs on TIA-1 and
TIAR expression was assessed by western blotting (Figure 1a)
and by semiquantitative and quantitative RT-PCR analyses
(Figure 1b). Under these experimental conditions, 80 to 90%
depletion of both TIA-1 and TIAR proteins (Figure 1a) and
mRNAs (Figure 1b) was achieved 72 h after transfection, in
agreement with previous findings [10,25-27]. In contrast,
U2AF65 and -tubulin proteins (Figure 1a) and -actin
mRNA (Figure 1b), used as controls for siRNA specificity,
were not significantly affected by the treatment.
In order to define gene expression profiles resulting from the
suppression of TIA-1 and TIAR expression, we assessed the
differences in global gene expression patterns in HeLa cells
transfected with siRNAs targeting both TIA-1 and TIAR com-
pared to HeLa cells transfected with control siRNA. Compar-
isons were made using hierarchical clustering analysis of gene
expression patterns from three array independent experi-
ments performed in three different biological samples for
each experimental condition tested (Additional data file 1). As
shown in Figure 2a, depletion of TIA-1 and TIAR resulted in a
marked alteration in the usual expression patterns of genes.
To identify cohorts of genes regulated by TIA proteins, the
gene expression array dataset was analyzed using Robust
RNA interference-mediated depletion of TIA proteins in HeLa cells Figure 1
RNA interference-mediated depletion of TIA proteins in HeLa cells. (a) 
Immunoblot analysis of HeLa cell lysates (5 g (lane 1; C(1/5)) or 25 g 
(lanes 2 to 5)) prepared 72 h after transfection with siRNAs against 
control (C; lanes 1 and 2), TIA-1 (lane 3), TIAR (lane 4), and TIA-1 plus 
TIAR (lane 5; 1+R). TIA-1(a/b) and TIAR(a/b) refer to the major isoforms 
of TIA-1 and TIAR, respectively. The blot was probed with antibodies 
against TIA-1, TIAR, U2AF65 and -tubulin proteins, as indicated. 
Molecular weight markers and the identities of protein bands are shown. 
The intensities of the different protein bands from immunoblots were 
quantified by densitometry. The represented values were normalized and 
are expressed relative to -tubulin (-Tub), whose value is fixed 
arbitrarily to 1, and are means ± standard error of the mean (SEM; n = 10; 
*P < 0.05). (b) Cytoplasmic mRNAs from post-transfected HeLa cells in 
(a) were analyzed by RT-PCR. Positions of size markers and the predicted 
alternatively spliced products are indicated. Quantification of relative 
levels of TIA-1, TIAR and -actin mRNAs in the above post-tranfected 
HeLa cells by real time RT-PCR. The represented values were normalized 
and are expressed relative to -actin mRNA, whose value is fixed 
arbitrarily to 1, and are means ± SEM (n = 3; *P < 0.01).
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Multichip Average [28] normalization followed by identifica-
tion of differentially expressed genes using the Rank Products
method [29]. In these analyses, only genes showing at least a
1.5-fold difference in expression compared to the control were
considered. A total of 472 genes were differentially expressed
(P < 0.05), of which 73 and 399 were up- and down-regulated,
respectively (Figure 2b; Additional data file 2).
In an attempt to address the functional relevance of the
observed changes in high-density DNA microarrays, Gene
Ontology (GO) analyses were performed for the up- and
down-regulated genes. GO analysis was able to identify the
main categories that had significant representation (P < 0.01)
of differentially expressed genes controlled by TIA proteins
(Figure 2c, d; Additional data file 3). GO categories related to
inflammation and immune responses, cell proliferation, cell-
cell signaling, chemotaxis, cell motility, angiogenesis and
anagen were among the enriched categories in up-regulated
genes (Figure 2c). On the other hand, GO categories associ-
ated with apoptosis induction, humoral immune response,
Knockdown of TIA proteins activates an acute inflammation-promoting transcriptome Figure 2
Knockdown of TIA proteins activates an acute inflammation-promoting transcriptome. (a) Heat map representation depicting microarray data for genes 
that are differentially regulated by siRNA-mediated reduction of TIA-1 and TIAR. Mean fold-change values from three independent replicates for each 
biological condition tested are given for 538 probe sets (horizontal lanes; out of a total of 47,400 sets) that were detectable above background showing at 
least a 1.5-fold change in expression and were statistically different (P < 0.05) in the two experimental conditions tested. Red and green indicate up- and 
down-regulation, respectively, relative to control siRNA-transfected HeLa cells. The color scale to the right indicates the magnitude of the fold change 
(base 2 logarithm) for a particular transcript. (b) Total number of genes whose expression was up- or down-regulated in TIA-1 and TIAR-depleted cells. 
(c, d) Graphic pie representations of the distribution of up- (c) and down-regulated (d) genes (P < 0.01) using the GO biological process category. (e, f) 
Graphic pie representations of the distribution of up- (e) and down-regulated (f) genes (P < 0.05) using the KEGG pathway database. In all cases (c-f), 
percentages shown reflect the portion of total genes that are associated with the biological functions and pathways indicated.
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cell differentiation and chromatin modifications were partic-
ularly prevalent in down-regulated genes (Figure 2d).
In the same vein, Kyoto Encyclopedia of Genes and Genomes
(KEGG) database analysis integrating individual components
into unified pathways was used to identify the enrichment of
specific pathway components in functionally regulated gene
groups (Figure 2e, f; Additional data file 3). The results indi-
cate that six KEGG pathways were significantly enriched (P <
0.05) in up-regulated genes, including cytokine-cytokine
receptor interaction, apoptosis inhibition, epithelial cell sign-
aling in Helicobacter pylori infection, hematopoietic cell lin-
eage, Toll-like receptor signaling pathway and gamma-
hexachlorocyclohexane degradation (Figure 2e; Additional
data file 3), and five KEGG pathways were significantly
enriched (P < 0.05) in down-regulated genes, involving sev-
eral metabolic pathways such as tryptophan metabolism,
amino acid degradation, propionate metabolism, limonene
and pinene degradation and vitamin B6 metabolism (Figure
2f; Additional data file 3).
Taken together, these results suggest the activation of inflam-
mation and proliferation-promoting pathways followed by
alterations in apoptotic and immune responses as well as in
cell signaling and metabolism that can mediate or modulate
their own pathway or the cross-talk between pathways that
account for the functional reprogramming of TIA-1/TIAR-
depleted HeLa cells.
Distinct and overlapping functions of TIA-1 and TIAR 
in the control of the transcriptome
To determine whether TIA-1 and TIAR have selective and
specific effects on the control of the gene expression pathways
described above, we next performed gene expression profil-
ing analyses in HeLa cells in which either TIA-1 or TIAR was
inactivated (Additional data files 4 and Additional data files
5). Inactivation of TIA-1 revealed 124 differentially expressed
genes (P < 0.05), of which 36 and 88 were up- and down-reg-
ulated, respectively (Additional data file 4). On the other
hand, knockdown of TIAR resulted in the differential expres-
sion (P < 0.05) of 94 genes, of which 23 and 71 were up- and
down-regulated, respectively (Additional data file 5).
Next, GO biological process categories and KEGG pathway
analyses were performed as before. A summary of GO anno-
tations by biological process categories is provided in Addi-
tional data file 6a-d. GO categories (P < 0.01) associated with
both TIA-1 (Additional data files 6a and Additional data files
7) and TIAR (Additional data files 6b and Additional data files
8) knockdown are related to inflammation and cell prolifera-
tion processes, including up-regulated genes in the following
categories: cell-cell signaling, inflammatory response, chem-
otaxis, negative and positive regulation of cell proliferation,
immune response, G-protein coupled receptor protein signal-
ing pathway, cell adhesion, angiogenesis, cell motility, trans-
duction and cell surface receptor mediated signaling. These
results agree with the observations previously found in HeLa
cells under TIA-1 and TIAR double silencing (Figure 2c), indi-
cating that TIA-1 and TIAR are redundant in the control of
these pathways. However, GO categories (P < 0.01) of down-
regulated genes associated with the depletion of either TIA-1
(Additional data files 6c and Additional data files 7) or TIAR
(Additional data files 6d and Additional data files 8) showed
striking differences in the gene clusters. Indeed, whereas GO
categories of down-regulated genes in TIA-1 knockdown cells
are linked to genes involved in apoptosis induction, negative
regulation of cytokine biosynthesis and metabolic responses
(Additional data files 6c and Additional data files 7, GO cate-
g o r i e s  o f  d o w n - r e g u l a t e d  g e n e s  i n  T I A R  k n o c k d o w n  c e l l s
were limited to genes implicated in RNA processing (Addi-
tional data files 6d and Additional data files 8).
Results from KEGG pathway analysis (P < 0.05) are provided
in Additional data file 6e-h. KEGG data for up-regulated
genes in TIA-1 (Additional data files 6e and Additional data
files 7) and TIAR (Additional data files 6f and Additional data
files 8) knockdown cells are associated with genes related to
cytokine-cytokine receptor interaction, apoptosis inhibition,
and immune, chemotaxis, inflammatory, proliferative and
metabolic responses, in agreement with the results described
above (Additional data file 6a, b). On the other hand, KEGG
data for down-regulated genes in TIA-1 knockdown cells are
linked to vascular epidermal growth factor signaling pathway
and citrate and reductive carboxylase cycles (Additional data
files 6g and Additional data files 7), and KEGG data for TIAR
knockdown cells are associated with several pathways related
to the metabolism of amino acids, vitamins, fatty acids, glyc-
erophospholipids and energy availability (Additional data
files 6h and Additional data files 8), suggesting that both TIA-
1 and TIAR can regulate specific aspects of cell metabolism.
Collectively, these results indicate that TIA-1 and TIAR regu-
late specific and overlapping aspects of the transcriptome,
suggesting that their functional effects can be redundant,
additive and/or independent, in agreement with previous
findings [8,12,21,27].
A molecular hallmark involving cytokines, chemokines 
and growth-stimulating factors is associated with the 
depletion of TIA proteins
To test whether reduced expression of TIA proteins is associ-
ated with the regulation of characteristic gene clusters, up-
and down-regulated genes were distributed using Venn dia-
grams (Figure 3a). In these analyses, we identified a gene sig-
nature involving nine up- and six down-regulated genes
(Figure 3a). This gene signature is composed of up-regulated
genes, including IL-8, AREG, GDF15, IL-6, EREG, KYNU,
PTGS2,  CXCL1  and  CXCL2  (Figure 3b, indicated in red)
which are mediators of inflammation, cell-cell signaling, cell
proliferation, tryptophan metabolism, immune and angio-
genesis responses, and down-regulated genes such as
RAB40B, TMSL8, UCP2, PAK3, TIA-1 and TIAR (Figure 3b,http://genomebiology.com/2009/10/8/R87 Genome Biology 2009,     Volume 10, Issue 8, Article R87       Reyes et al. R87.5
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indicated in green), which represent a set of heterogeneous
genes implicated in protein transport and phosphorylation,
cytoskeleton organization and biogenesis, control of the pro-
duction of reactive oxygen species/oxidative metabolism and
induction of apoptosis.
Validation of microarray-predicted changes in gene 
expression patterns
The effects on steady-state mRNA levels detected by the
microarray were independently validated using quantitative
RT-PCR assays for 26 different genes. Figure 4a shows valida-
tion of predicted up-regulated (EREG, PTGS2, IL-1A, IL-6,
IL-8, AREG, GDF15, CXCL1, CXCL2 and KYNU) and down-
regulated (TIA-1,  TIAR,  PAK3,  TMSL8,  UCP2,  CD24,
TNFSF10,  RAB40B,  MMP2,  TIMP2,  FASTK  and  TFDP2)
genes that were increased or decreased, respectively, by
depletion of TIA-1 and TIAR in HeLa cells. As expected, the
results confirmed predicted up- and down-regulation for all
genes analyzed (Figure 4a). Furthermore, APPBP2, MTFR1,
-actin and OPN1 genes were used as controls (Figure 4a).
Additionally, to know whether TIA-1 and TIAR have additive,
overlapping or synergistic effects on steady-state target
mRNA levels, some up-regulated (IL-6, IL-8, AREG, PTGS2
and EREG) and down-regulated (TNFSF10 and CD24) genes,
as well as the -actin gene as a control, were also validated by
quantitative RT-PCR with independent silencing of either
TIA-1 or TIAR. As shown in Figure 4b, depletion of TIA-1 or/
and TIAR did affect partially the steady-state levels of ana-
lyzed mRNAs, showing that the actions of TIA proteins are
additive and overlapping rather than synergistic. Taken
together, these results are fully consistent with the observa-
tions performed by microarray analyses, suggesting that
Identification of a gene cluster associated with the silencing of TIA proteins Figure 3
Identification of a gene cluster associated with the silencing of TIA proteins. (a) Venn diagrams depicting the numbers of genes that were up-regulated 
(left) or down-regulated (right) by TIA-1 (green), TIAR (red) or TIA-1 plus TIAR (blue) silencing. All data for all genes are presented in Additional data files 
2 to 5 and 7 and 8. (b) Gene cluster defining a molecular signature of up- (highlighted in red) and down-regulated (highlighted in green) genes in TIA-1 and 
TIAR-depleted HeLa cells. The microarray data were analyzed by the Rank Products method [29]. Fold is an average measure of the fold change in 
differential expression and the false discovery rate (FDR) indicates the expected percentage of false positives. The Probe-set ID is the Unigene probe-set 
identifier [43].
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some changes observed in our microarray experiments could
represent putative novel target genes regulated by TIA-1 and/
or TIAR proteins.
Depletion of TIA proteins alters both mRNA stability 
and basal gene transcription
To determine the mechanism underlying the alterations in
gene expression observed through inactivation of TIA pro-
teins, HeLa cells transfected with control siRNA or with TIA-
1 and TIAR siRNAs were treated with actinomycin D, a selec-
tive inhibitor of RNA polymerase II (Figure 5a, b). The results
suggest an effect on mRNA stability, as indicated by the
steady-state mRNA levels of PTGS2, GDF15, IL-8, TIMP2 and
TNFSF10  in TIA-1/TIAR-depleted HeLa cells (Figure 5a).
However, the specific contribution of mRNA turnover can not
be measured accurately in control HeLa cells because steady-
state levels of some target mRNAs are extremely low. Perhaps
a stressing stimulus that enhances mRNA decay is needed in
order to establish properly whether TIA proteins affect
mRNA stability. Additionally, some representative genes
were also quantified at the protein level by western blotting.
Figure 5b shows the results of TIA-1, TIAR and Prostaglan-
din-endoperoxide synthase 2 (PTGS2) protein expression
levels, which are consistent with the real-time PCR results. As
controls, Mcl-1 protein expression was specifically affected by
the treatment with actinomycin D, but HuR and -tubulin
Validation of microarray-predicted changes by quantitative RT-PCR (qRT-PCR) Figure 4
Validation of microarray-predicted changes by quantitative RT-PCR (qRT-PCR). (a) Differential expression of 26 genes, 10 up-regulated (bottom bars), 12 
down-regulated (top bars) and 4 unchanged (middle bars), was verified by real time RT-PCR using specific primer pairs (Additional data file 11). The 
represented values were normalized and are expressed relative to -actin, whose value is fixed arbitrarily to 1, and are means ± standard error of the 
mean (SEM; n = 3; *P < 0.001; **P < 0.01; ***P < 0.05). (b) Differential expression of eight genes, five up-regulated (IL-6, IL-8, AREG, PTGS2 and EREG), two 
down-regulated (TNFSF10 and CD24) and one unaffected (-actin), from cytoplasmic RNA isolated from HeLa cells transfected with either control (white 
bars), TIA-1 (grey bars), TIAR (dark grey bars) or TIA-1 plus TIAR (black bars) siRNAs was verified as above. The represented values were normalized and 
are expressed relative to -actin, whose value is fixed arbitrarily to 1, and are means ± SEM (n = 3; *P < 0.001; **P < 0.01).
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Figure 5 (see legend on next page)
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protein expression was not modified by either TIA-1 and
TIAR depletion or by the treatment with actinomycin D
(Figure 5b).
Given that the results on mRNA turnover do not conclusively
explain the steady-state target mRNA levels in TIA-1/TIAR-
depleted HeLa cells, we decided to estimate the contribution
of the TIA-1/TIAR-induced silencing on transcription activa-
tion of two target genes. For this purpose, control and TIA-1/
TIAR-depleted HeLa cells were cotransfected transiently with
PTGS2 and IL-6 promoter-driven firefly luciferase constructs
[30,31] and a -galactosidase-expressing plasmid used as a
transfection control. Sixteen hours after transfection, cells
were stimulated with dimethyl sulfoxide (DMSO) or phorbol
12-myristate 13-acetate (PMA), as described in the Materials
and methods section, and 6 hours after stimulation both luci-
ferase and -galactosidase activities were measured in whole-
cell extracts. As shown in Figure 5c, d, the depletion of TIA
proteins was able to promote a significant and reproducible
induction (2- to 2.5-fold) of both luciferase constructs under
the control of PTGS2 (Figure 5c) and IL-6 (Figure 5d) human
promoter sequences, suggesting that reduced expression of
TIA proteins deregulates the basal transcriptional activity of
both promoters. Taken together, these results could suggest
that the gene expression patterns detected in TIA-1/TIAR-
depleted HeLa cells might be the result of an overlapping reg-
ulation, implying the involvement of several molecular events
at the post-transcriptional and transcriptional levels.
Silencing of TIA proteins results in increased cell 
proliferation and anchorage-independent growth
As shown in Figure 2 and in Additional data file 6, GO analy-
ses suggested a role for TIA-1 and TIAR proteins in the con-
trol of cell proliferation. Thus, to validate at the functional
level the results obtained with the GO analyses and to deter-
mine the putative role of TIA-1 and TIAR on cell proliferation,
we examined the proliferative potential of HeLa cells with
diminished expression of TIA-1 and/or TIAR. As shown in
Figure 6, reduction of TIA-1 and/or TIAR expression in HeLa
cells resulted in increased cell proliferation compared to con-
trol cells. Indeed, total cell numbers (Figure 6a) as well as
measurement of metabolic activity by methyl thiazolyl tetra-
zolium assay (Figure 6b) support an individual and collective
role for TIA proteins in the control of cell proliferation. Fur-
thermore, TIA-1 and/or TIAR silencing promoted a signifi-
cant increase in the proportion of cells in S and G2/M phases
concurrent with a reduction in the proportion of cells in G0/
G1 (Figure 6c). Most interestingly, the colony-forming capac-
ity in plaque (Figure 6d) and soft agar (Figure 6e) was sub-
stantially increased in TIA-1/TIAR-depleted cells compared
with the corresponding control cells. In addition, the number
of colonies as well as the number of cells per colony were sig-
nificantly increased in HeLa cells lacking TIA proteins (Fig-
ure 6d, e, left and right panels, respectively). Altogether, these
results indicate that the knockdown of TIA-1 and TIAR pro-
teins in HeLa cells triggers cell proliferation and anchorage-
independent growth.
Discussion
Gene expression profiling has revolutionized our ability to
understand the concerted and global response of the human
transcriptome at the molecular level. Collectively, our data
suggest that either expression or suppression of TIA-1 and/or
TIAR proteins triggers pathway-specific and biologically
coherent regulatory programs linked to an acute inflamma-
tion and cell proliferation-promoting transcriptome. They
also reveal that TIA proteins can provide a novel regulatory
layer of mechanisms for cross-talk between different path-
ways that coordinate cellular phenotypes such as metabolic
homeostasis, cell survival and growth. Most importantly, we
would like to indicate that our findings agree with and can
explain at the molecular level previous observations based on
mice models where suppression of TIA-1 expression pro-
motes chronic inflammatory responses as well [32].
A molecular hallmark associated with the depletion of TIA
proteins comprises a gene signature including those encoding
Silencing of TIA proteins alters both mRNA stability and gene transcription Figure 5 (see previous page)
Silencing of TIA proteins alters both mRNA stability and gene transcription. (a) DNA transcription was inhibited in control and TIA-1/TIAR-depleted 
HeLa cells by the addition of actinomycin D (Act D; 5 g/ml) to the culture medium. Cytoplasmic RNA was isolated at various times (0, 3 and 6 h) after 
the addition of the inhibitor Act D and analyzed by real time RT-PCR. Relative levels of -actin, PTGS2, GDF15, IL-8, TIMP2 and TNFSF10 mRNAs were 
determined with the specific primer pairs (Additional data file 11). A representative experiment is shown. Steady-state RNA levels are represented at 
various times after the addition of Act D. Open and closed circles illustrate relative RNA levels in control (C) and TIA-1/TIAR (1+R)-depleted samples, 
respectively. (b) Validation of differential expression for selected genes by western blot analysis. Protein extracts (5 g (lane 1; C(1/5)) or 25 g (lanes 2 
to 8)) derived from post-transfected HeLa cells with control (lanes 1 to 5) and TIA-1 and TIAR (lanes 6 to 8) siRNAs and treated with Act D as in (a) were 
analyzed with the indicated antibodies. A representative blot is shown. Molecular weight markers and the identities of protein bands are indicated. TIA-
1(a/b) and TIAR(a/b) refer to the major isoforms of TIA-1 and TIAR, respectively. (c, d) Effect of the TIA-1/TIAR silencing on transcriptional activation of 
the PTGS2 (c) and IL-6 (d) gene promoters. A schematic representation of PTGS2 (c) and IL-6 (d) human gene promoters is shown. In both cases, cis-acting 
consensus sequences are represented by boxes. Control and TIA-1/TIAR-depleted HeLa cells were transiently cotransfected with PTGS2 or IL-6 
promoter-driven firefly luciferase constructs together with a -galactosidase-expressing plasmid (used as a transfection control) as described in Materials 
and methods. Sixteen hours after cotransfection, cells were cultured in the presence of DMSO or 20 ng/ml PMA for 6 h and assayed for luciferase and -
galactosidase activities. The represented values in (c, d) - the ratio between luciferase relative light units (RLU)/-galactosidase activity - were normalized 
and are expressed relative to the control sample treated with DMSO, whose value is fixed arbitrarily to 1, and are means ± standard error of the mean (n 
= 3; *P < 0.001 in (c); *P < 0.01 in (d)).http://genomebiology.com/2009/10/8/R87 Genome Biology 2009,     Volume 10, Issue 8, Article R87       Reyes et al. R87.9
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pro-inflammatory cytokines (IL-1A and IL-6), inflammatory
chemokines (CXCL1, CXCL2 and IL-8), growth-stimulating
factors (AREG, EREG and GDF15) and pro-angiogenic induc-
ers (PTGS2 and IL-8) as well as the RAS oncogene family
member  RAB40B, regulators of cytoskeleton organization
and biogenesis (TMSL8  and  PAK3) and a mitochondrial
modulator (UCP2). This gene cluster contains the ensemble
of gene functions that may coordinately work to activate the
acquisition of cell proliferation and anchorage-independent
cell growth phenotypes observed in TIA-1/TIAR-depleted
cells. Using a bioinformatic tool (the Pathway Studio software
(version 6.0) and the 'ResNet Mammalian' database devel-
Depletion of TIA proteins activates cell proliferation and anchorage-independent growth Figure 6
Depletion of TIA proteins activates cell proliferation and anchorage-independent growth. (a) Post-transfected HeLa cells with siRNAs against control (C; 
white diamond), TIA-1 (1; grey square), TIAR (R; grey circle) or TIA-1 plus TIAR (1+R; black circle) were seeded in six-well plates and the number was 
counted on the days indicated for 6 days. Each time point represents the means ± standard error of the mean (SEM; n = 3 to 6; *P < 0.01). (b) Cells grown 
for 6 days as in (a) were monitored by methyl thiazolyl tetrazolium (MTT) assays. The represented values were normalized and are expressed relative to 
control (C), whose value is fixed arbitrarily to 1, and are means ± SEM (n = 3 to 5; *P < 0.001). (c) Analysis of cell-cycle phases by flow cytometry after 
propidium iodide staining. The data are means ± SEM (n = 3; *P < 0.01; **P < 0.05). (d) Representative photographs of colonies generated from 
transfected HeLa cells. One week after seeding 2,000 cells in a 6-well plate, the cells were fixed in paraformaldehyde (5%), stained with crystal violet 
(0.01%) and quantified by light microscopy. The represented values are the means ± SEM from three independent experiments performed in duplicate for 
at least eleven independent colonies (*P < 0.001). A colony was defined as a cell cluster when containing at least 86 cells. Scale bars represent 200 m. (e) 
Soft-agar colony formation. In each 6-well plate, 5,000 post-transfected HeLa cells as above were seeded into soft-agar matrix and incubated for 14 days. 
The cell number was counted under a light microscope after staining with crystal violet as before. The represented values are means ± SEM for three 
independent experiments performed in duplicate for at least 36 counted fields (*P < 0.001; **P < 0.01). In this case, a colony was defined as a cell cluster 
containing at least 4 cells. Scale bars represent 100 m.
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oped by Ariadne Genomics), a gene network based on bio-
chemical data was created for experimentally determined
interactions between clusters of up- and down-regulated
genes associated with the depletion of TIA-1 and TIAR in
HeLa cells (Figure 7; Additional data file 9). This network
suggests a cellular scenario where silencing of these proteins
leads to increased expression of a gene cluster encoding com-
ponents of inflammation, angiogenesis and cell growth sign-
aling, with a predicted enhancer effect on these pathways
(Figure 7; Additional data file 9). This in silico simulation
could integrate our results at a molecular level as well as pre-
vious observations on the importance of the cell-cell signal-
ing, chemotaxis, adhesion, angiogenesis and immune
responses mediated by interleukins, chemokines and growth-
stimulating factors in molecularly connecting chronic inflam-
mation and compensatory proliferation [33,34].
Why should inflammation and cell proliferation signaling
result in a coherent transcriptional and post-transcriptional
program of gene regulation targeting similar classes of genes?
Promotion of cell proliferation and growth can be achieved
through either abnormally activated or deregulated signaling
pathways involved in cell cycle regulation or, quite often,
abnormal growth signals outside the transformed cell, which
are usually not considered. In this regard, TIA-1/TIAR target
genes regulating proliferation include those encoding
growth- and survival-stimulating factors, such as the epider-
mal growth factor receptor (EGFR)/pan-HER ligand epiregu-
lin (EREG), the epidermal growth factor-like growth factor
amphiregulin (AREG), and a member of the transforming
growth factor-beta (TGF-beta) superfamily known as growth
differentiation factor-15 (GDF15) (Figure 7). Moreover, the
cellular processes and pathways promoting these growth-
stimulating factors can be reinforced by IL-6 and IL-8, the
chemokines CXCL1 and 2 and cyclooxygenase-2, which con-
tribute to cell growth through self-sufficiency in growth sig-
nals, evasion of apoptosis, insensitivity to growth inhibitors
as well as inflammatory and angiogenic potential responses
[33-36].
These findings provide novel insights into the critical role of
individual regulators such as TIA proteins to control, indi-
Interaction network associated with the gene cluster induced upon suppression of TIA proteins Figure 7
Interaction network associated with the gene cluster induced upon suppression of TIA proteins. Visualization of biochemical relationships between gene 
clusters up-regulated (red) and down-regulated (green) identified by microarray analyses were computed using the Pathway Studio (version 6.0) software 
and the 'ResNet Mammalian' database developed by Ariadne Genomics, Inc. [40]. The network topology illustrates positive (red boxes) and negative 
(green boxes)-regulated cell processes based on interactions after inactivation of TIA proteins. The nature of the regulators is depicted schematically as 
shown in the legend to the right. Continuous and dotted lines illustrate direct and indirect protein-protein interactions, respectively. The thickness of blue 
lines is proportional to the number of interactions reported in the literature.
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rectly rather than directly, protein output from hundreds of
target genes in a given cellular context. These regulators may
impact physiological processes by regulating the concentra-
tions of a few key cellular proteins that may be components of
a single or functionally interrelated pathways. This is an
interesting observation because it suggests that the molecular
links that lead to gene expression control are intimately inter-
connected, pointing to a widespread role for TIA proteins in
the negative regulation of transcriptional rates of the human
genome. Thus, these proteins may function as adaptors or
coupling factors to facilitate cross-talk between different lay-
ers that define the complex interactions involved in the regu-
lation of the human transcriptome.
A close inspection of differentially expressed genes between
control versus TIA-1/TIAR-depleted HeLa cells reveals the
up-regulation of cell-cycle activators such as CDC23 and the
down-regulation of cell-cycle suppressors such as CHES1,
MPHOSPH9, CCNB1 (encoding cyclin B1), ANAPC7, NASP
and CDC7, which could also account for the enhanced prolif-
eration. Additionally, genes for cell-cycle controlling tran-
scription factors - for example, TFDP1, TFDP2 and E2F8 - as
well as other cell-cycle progression related factors - UHRF1,
BARD1,  RABGAP1,  PSRC1,  PCGF6  and  SEPT6  - are also
down-regulated in HeLa cells with TIA-1/TIAR-induced
silencing (Additional data files 9 and Additional data files 10).
To our knowledge, this is the first study to analyze, in parallel,
global transcriptomic and phenotypic impacts after changes
in the expression and/or function of TIA proteins.
What could be the molecular mechanism that mediates the
changes in steady-state mRNA levels triggered by TIA pro-
teins? We propose that, in addition to mediating some of the
signaling effects of the cytokines, chemokines and growth-
stimulating factors, the putative molecular mechanism may
implicate the activation of basal transcriptional machinery
through up-regulation of the gene TAF5L as well genes for
nuclear transcription factors - for example, the CREM and
MAFF families - together with the down-regulation of genes
for transcription repressors, such as PCGF2, NR2F2, SUDS3
and PCGF6 (Additional data files 9 and Additional data files
10). Constitutive activation/repression of basal transcrip-
tional machinery and/or selective transcription factors is an
emerging hallmark of various transformed cell types [33-35].
In addition, they have specifically been implicated in the
development of proliferative phenotypes through autocrine
and paracrine mechanisms. Our TIA-1/TIAR silencing signa-
ture is associated with the up-regulation of critical NF-B and
CREM effectors, including CXCL1, CXCL2, PTGS2, IL-6 or
IL-8, which have been implicated in cell proliferation and
growth [33-35]. In summary, TIA-1/TIAR-depleted HeLa
cells are characterized by a molecular signature indicative of
global and constitutive activation of NF-B and CREM down-
stream effector genes associated with cell proliferation. Pre-
sumably, the up-regulation of genes required for
proliferation, survival and inhibition of apoptosis might be
essential for anchorage-independent growth. These conjec-
tures, however, will have to be proven by additional studies in
order to determine the precise role of these genes in the phe-
notypes observed in this study.
Nevertheless, the coordinate expression of inflammation
and/or growth-stimulating genes requires both transcrip-
tional and post-transcriptional regulation [34]. Indeed, this
gene coordination is also able to exert a positive effect on
inflammation and cell proliferation or a positive feedback
control on these pathways by regulating the expression of
some of its components in TIA-1/TIAR-dependent regulatory
events. These multifunctional proteins have been implicated
in several steps of RNA dynamics and metabolism, including
transcription, RNA splicing, RNA stability and translation,
but little is known about the putative mechanisms and selec-
tivity of transcriptional repression exerted by these proteins.
It is important to note that these regulators have been local-
ized on the carboxy-terminal domain of RNA polymerase II
[2]; therefore, they could interact with basal transcription
machinery and influence its activity. In addition, both pro-
teins contain three RNA-binding motifs and are structurally
close to heterogeneous ribonucleoproteins [5]. Consistently,
both TIA proteins directly bind to RNA as well as to single-
and double-stranded DNA [3-5]. It is tempting to speculate
that TIA proteins could also interact with specific promoter
sequences and/or with gene-specific/general transcription
factors [3,4]. In this regard, it is more than reasonable to sug-
gest that these proteins can carry out functions during tran-
scription. Further, an increasing body of evidence indicates
that transcription and RNA splicing processes are coupled
[2].
Collectively, we postulate that, during transcription, TIA-1
and/or TIAR proteins can be recruited from the carboxy-ter-
minal domain of RNA polymerase II to interact with genomic
DNA sequences and/or basal transcription machinery and
subsequently slow down RNA polymerase II and, therefore,
the rate of transcription. Moreover, these proteins can per-
form triple functions during chromatin structure organiza-
tion, transcription and splicing because they can potentially
shuttle between DNA and RNA substrates and it has been
demonstrated that factors affecting the rate of RNA polymer-
ase II-mediated transcriptional elongation/initiation could
influence alternative splicing patterns [2].
On the other hand, the prevalent role of these proteins as gene
expression post-transcriptional modulators in the regulation
of processes of alternative pre-mRNA splicing as well as their
role in the stability and translation of specific cellular mRNAs
is well-documented [8,12-14,22-24]. TIA proteins regulate
the alternative pre-mRNA splicing of approximately 15% of
alternative cassette human exons through binding to U-rich
intronic elements, facilitating atypical 5' splice site recogni-
tion by U1 small nuclear ribonucleoproteins [6-10]. These
proteins have also been well characterized as regulators of thehttp://genomebiology.com/2009/10/8/R87 Genome Biology 2009,     Volume 10, Issue 8, Article R87       Reyes et al. R87.12
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stability and translation of cellular mRNAs in the cytosol. The
proteins have been implicated in stress-induced translational
arrest, colocalizing after stress with poly(A)+ RNA in the cyto-
plasmic foci known as stress granules [15]. TIA-1 and TIAR
are both able to bind to the 3'-untranslated regions of the sta-
bility/translation regulatory U- and AU-rich elements [5,11-
14,16]. This aspect of TIA-1/TIAR function has recently been
the focus of a broad and systematic analysis to identify
mRNAs associated with both RNA-binding proteins [22-24].
However, it is interesting to note that no overlap is observed
between gene targets reported to be repressed by TIA-1 at the
translation level [22] and genes regulated by TIA1/TIAR at
the alternative splicing level [8]. This suggests that TIA pro-
teins regulate distinct subsets of genes at the splicing and
translation levels. Indeed, TIA-1 and/or TIAR proteins might
independently switch on/off molecular plasticity in gene reg-
ulation machineries such as transcription, alternative splic-
ing, stability and/or translation to coordinate the
establishment of the diversity of specific transcriptomes and
proteomes that are required in complex cellular responses
such as cell proliferation and growth. Thus, the roles of these
regulators and further newly identified targets in these phys-
iological processes deserve further investigation.
Conclusions
The data presented in this manuscript illustrate specific
changes in transcriptomic dynamics associated with cell-cell
signaling, immuno-suppression, inflammation, angiogenesis,
metabolism and cell proliferation-related mRNAs upon
silencing of TIA-1 and/or TIAR proteins in HeLa cells. A gene
cluster including cytokines, chemokines and growth-stimu-
lating factors was identified as a molecular hallmark/signa-
ture associated with the depletion of TIA proteins. From a
mechanistic viewpoint, TIA proteins could modulate tran-
scriptional and post-transcriptional events associated with
the control of target gene promoter basal activity and specific
mRNA turnover. Additionally, the results also show that the
knockdown of TIA-1 and/or TIAR proteins in HeLa cells trig-
gers cell proliferation and anchorage-independent growth. In
silico simulation of a biochemical interaction network incor-
porating up- and down-regulated target genes is consistent
with a set of functions coherent with the different roles of sev-
eral in vivo pathways to activate the acquisition of cell prolif-
eration and anchorage-independent growth phenotypes
detected after TIA-1/TIAR silencing. Collectively, our results
argue that silencing of TIA proteins can trigger pathway-spe-
cific changes and affect genes with coherent functions that are
important for cell proliferation and growth responses.
Materials and methods
Cell culture and RNA interference analysis
HeLa S2 cells were processed and RNA interference experi-
ments were carried out as described previously [10,25-27].
Transfections, luciferase and -galatosidase assays
The human PTGS2  promoter [GenBank:AF276953.2] con-
struct containing the full-length promoter sequence fused to
a firefly luciferase reporter gene, named p2-1900 (-1,796,
+104), was generated as described previously [30]. The
human IL-6 gene promoter [GenBank:AF372214.2] construct
containing a 651-bp fragment of the human promoter
sequence was fused to a firefly luciferase reporter gene,
named pIL-6-luc651, as described previously [31]. Both con-
structs were kindly provided by Dr Y Revilla. The -galactos-
idase plasmid pcDNA3.1/myc-His/lacZ  (Invitrogen,
Carlsbad, CA, USA) was kindly provided by Dr J Berlanga.
Control and TIA-1/TIAR-depleted HeLa cells, as described
above, were co-transfected transiently with 50 and 500 ng of
specific reporter lacZ and firefly luciferase plasmids, respec-
tively, in six-well plates. The cells were incubated at 37°C for
1 6  h  a n d  t h e n  p o s t - t r a n s f e c t e d  c e l l s  w e r e  s t i m u l a t e d  w i t h
DMSO or 20 ng/ml of PMA in DMSO. Six hours after stimu-
lation, cells were lysed with 200 l of cell culture lysis reagent
(Promega, Madison, WI, USA) and microcentrifuged at
14,000 rpm for 5 minutes at 4°C, and 20 and 40 l of each
supernatant was used to determine firefly luciferase activity
in a Monolight 2010 luminometer (Analytical Luminescence
Laboratory, San Diego, CA, USA). -Galactosidase activity
was measured as described previously [37]. Luciferase activ-
ity was expressed as relative light units (RLU) per milligram
of protein determined by the bicinchoninic acid method
(Pierce, Rockford, IL, USA) and normalized to -galactosi-
dase-specific activity expressed as nmoles of hydrolyzed o-
nitrophenyl--D-galactopyranoside (Sigma, St. Louis, MO,
USA) per minute and milligram of protein at 37°C. Co-trans-
fection experiments were performed in triplicate and the data
are presented as the means of the ratio RLU/-galactosidase,
expressed as fold induction relative to the corresponding con-
trol values (means ± standard error of the mean).
Proliferation and cell-cycle analyses
For cell growth analysis, post-transfected HeLa cells (2 × 104)
were seeded and collected for counting from triplicate at the
indicated time points for 6 days. Cell proliferation was also
quantified by measuring the conversion of methyl thiazolyl
tetrazolium into DMSO-soluble formazan by living cells, with
absorbance measured at 560 nm using a spectrophotometer.
Cell-cycle analysis was carried out by flow cytometry after
propidium iodide staining.
Anchorage-independent growth assays
Soft agar colony formation was assayed by plating in dupli-
cate 1 × 103 cells in 0.35% agarose in 10% fetal calf serum con-
taining media on a 0.8% agarose base in six-well plates. After
14 days, the resulting colonies were stained with 0.01% crystal
violet solution, counted and photographed under a light
microscope at 100× magnification.http://genomebiology.com/2009/10/8/R87 Genome Biology 2009,     Volume 10, Issue 8, Article R87       Reyes et al. R87.13
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Preparation of cell extracts and western blot analysis
Whole-cell extracts were performed and processed as
described previously [25]. Immunoblots were carried out
using the following antibodies: anti-U2AF65 (MC3; provided
by J Valcárcel); anti-PTGS2 (provided by MA Íñiguez), anti-
TIA-1, anti-TIAR and anti-HuR (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), anti-Mcl-1 (Biomol, Farmingdale, NY,
USA) and anti--tubulin (Sigma, St. Louis, MO, USA).
RNA purification, semiquantitative and quantitative 
RT-PCR analyses and in vivo RNA decay determination
Cytoplasmic RNA isolations and semiquantitative RT-PCR
analysis were carried out as described previously [10,25-27].
The expression of selected genes was assessed independently
by quantitative RT-PCR as described in [37]. A list of primer
pairs is given in Additional data file 11. RNA turnover experi-
ments were performed by adding actinomycin D (5 g/ml) to
the growth medium.
Transcriptome analysis
RNA quality checks, amplification, labeling, hybridization
with Human Genome U133 Plus 2.0 Array Chips (approxi-
mately 55,000 transcripts; Affymetrix Inc., Santa Clara, CA,
USA) and initial data extraction were performed at the
Genomic Array Core Facility in Scientific Park, Madrid at the
Universidad Complutense de Madrid [38]. Comparison of
multiple cDNA array images (three independent experiments
per biological condition tested) was carried out by using an
average of all of the gene signals on the array (global normal-
ization) to normalize the signal between arrays (Additional
data file 1). Heat map and sample clustering plots as well as
GO and KEGG database analyses were performed using soft-
ware programs provided by Integromics™ [39]. Networks of
biochemical relationships between gene clusters identified as
up-regulated and down-regulated by microarray analysis
were created using the Pathway Studio software (version 6.0)
and the 'ResNet Mammalian' database developed by Ariadne
Genomics, Inc. (Rockville, MD, USA) [40]. Microarray data
have been deposited in the EMBL-EBI ARRAY EXPRESS
database [41] and are accessible through the ArrayExpress
accession number [ArrayExpress:E-MTAB-93].
Statistical analysis
Represented values are shown as means ± standard error of
the mean. Differences were tested for significance by means
of the Student's t-test. TIA-1/TIAR siRNA effects on HeLa
cells were compared with respect to the control siRNA trans-
fection. A probability level P < 0.05 was considered signifi-
cant.
Abbreviations
AREG: amphiregulin; DMSO: dimethyl sulfoxide; EREG:
pan-HER ligand epiregulin; GDF: growth differentiation fac-
tor; GO: Gene Ontology; IL: interleukin; KEGG: Kyoto Ency-
clopedia of Genes and Genomes; NF: nuclear factor; RLU:
relative light units; siRNA: small interfering RNA; TIA-1: T-
cell intracellular antigen-1; TIAL1/TIAR: TIA-1 like/related
protein.
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Additional data files
The following additional data are available with the online
version of this paper: variability of data as function of the
mean (MvA), RNA digestion, raw and normalized data box
plots (Additional data file 1); summary of differentially
expressed genes in TIA-1 and TIAR-depleted HeLa cells
(Additional data file 2); summary of GO and KEGG database
analyses of microarray-predicted genes from TIA-1 and
TIAR-depleted HeLa cells (Additional data file 3); summary
of differentially expressed genes in TIA-1-depleted HeLa cells
(Additional data file 4); summary of differentially expressed
genes in TIAR-depleted HeLa cells (Additional data file 5);
global mRNA expression patterns in TIA-1 or TIAR-depleted
HeLa cells (Additional data file 6); summary of GO and KEGG
database analyses of microarray-predicted genes from TIA-1-
depleted HeLa cells (Additional data file 7); summary of GO
and KEGG database analyses of microarray-predicted genes
from TIAR-depleted HeLa cells (Additional data file 8); glo-
bal network of genes modulated after TIA-1 and TIAR silenc-
ing (Additional data file 9); list of genes up- and down-
regulated after TIA-1/TIAR silencing that function as tran-
scription and/or cell-cycle modulators (Additional data file
10); list of primer pair sequences used to validate microarray-
predicted genes by real-time PCR analysis (Additional data
file 11).
Additional data file 1 MvA, RNA digestion, raw and normalized data box plots (a) MvA plots. From left to right: MvA plots derived from high den- sity oligonucleotide arrays to define gene expression profiles from  control (C_1-3.CEL files) and TIA-1 (1_1-3.CEL files), TIAR (R_1- 3.CEL files) or TIA-1 plus TIAR (1+R_1-3.CEL files)-depleted HeLa  cells. This kind of plot is used to diagnose experimental problems  between different biological replicates. The ratio between array sig- nal intensities is illustrated on the y-axis (M) and intensity average  is represented on the x-axis (A). In this type of plot, if there are no  systematic differences between biological replicates, the dot map of  each array is concentrated on the axis M = 0. In all cases docu- mented in our experiments, there was no a significant variability  between different biological samples. (b) RNA digestion plots.  RNA degradation mainly started from the 5'-end and, therefore, a  greater loss of signal intensity occurred with the probes that  hybridize to the mRNA 5'-end than with complementary probes  close to the mRNA 3'-end. RNA degradation plots illustrate mRNA  intensity values versus the function of the positions corresponding  to the probes in the 5'-3' orientation. Each graphic on the plot illus- trates one array and the slope indicates the RNA degradation level  corresponding to each hybridized sample. Overall, a higher slope  indicates that more hybridized sample was degraded. This kind of  plot is likely to detect significant differences between hybridized  samples. Our results show that all samples behaved similarly, sug- gesting that there are no significant differences between biological  samples analyzed. (c) Box plots of crude (to the left) and normal- ized (to the right) data analyzed by the quantile technique. The  Data_rma.txt file submitted to the ArrayExpress database contains  processed data using the Robust Multichip Average method [28].  Every color indicates a characteristic group of biological samples  analyzed. Click here for file Additional data file 2 Summary of differentially expressed genes in TIA-1 and TIAR- depleted HeLa cells List of the significantly up- and down-regulated genes in TIA-1 and  TIAR-depleted HeLa cells analyzed by using Integromics™ soft- ware [39]. The studied gene parameters are as follow. Affymetrix  Probe Set ID: probe-set identifier of the Affymetrix database [42].  Average Fold Change: mean value of fold change, expressed as base  2 logarithm, for each gene between the compared situations. RP  Value Up: probability for a specific gene to be up-regulated.  Expected UP: expected value for a certain RP Value Up (it repre- sents the average number of times that an equal or better RP value  appears in randomized experiments). FDR Up: expected percent- age of false positives for up-regulated genes. RP Value Down: prob- ability for a specific gene to be down-regulated. Expected Down:  expected value for a certain RP Value Down. FDR Down: expected  percentage of false positives for down-regulated genes. Venn Up:  shows in which of the three compared situations (control versus  TIA-1 (T1), control versus TIAR (T2) or control versus TIA-1 and  TIAR (T3)) the gene is up-regulated. Venn Down: shows in which  of the three compared situations as above the gene is down-regu- lated. UniGene ID: identification number of each gene in the Uni- Gene database [43]. Gene Title: gene name. Gene Symbol: acronym  of each gene. Chromosomal Location: gene location on the chromo- some. Entrez Gene: probe-set identifier in the Entrez Gene data- base [44]. SwissProt: protein accession number in SwissProt  database [45]. OMIM: accession number in Online Mendelian  Inheritance in Man, a database for human genes and genetic disor- ders [46]. GO Biological Process, GO Cellular Component, GO  Molecular Function: accession number and description of the  assigned GO in biological process, cellular component and molecu- lar function categories [47]. Pathway: accession number and gene  pathway assigned in the biologically represented pathways of the  GenMAPP database [48]. InterPro: accession number in the Inter- Pro database and description of protein families and domains [49]. Click here for file Additional data file 3 Summary of GO and KEGG database analyses of microarray-pre- dicted genes from TIA-1 and TIAR-depleted HeLa cells Analyses of KEGG pathways and GO terms corresponding to the  biological process category were applied to differentially expressed  genes in TIA-1 and TIAR knockdown HeLa cells. Calculated P-val- ues for each pathway or category are shown. All analyses were per- formed using Integromics™ software [39]. Click here for file Additional data file 4 Summary of differentially expressed genes in TIA-1-depleted HeLa  cells List of the up- and down-regulated genes in TIA-1-depleted HeLa  cells. The analyzed databases were the same as in Additional data  file 2. Click here for file Additional data file 5 Summary of differentially expressed genes in TIAR-depleted HeLa  cells List of the up- and down-regulated genes in TIAR-depleted HeLa  cells. The analyzed databases were the same as in Additional data  file 2. Click here for file Additional data file 6 Global mRNA expression patterns in TIA-1 and TIAR-depleted  HeLa cells (a-h) Genome-wide microarrays were performed with TIA-1 or  TIAR-depleted HeLa cells as in Figure 2. (a-d) Graphic pie repre- sentations of the distribution of up- (a, b) and down-regulated (c,  d) genes (P < 0.01) in TIA-1 (a, c) or TIAR (b, d) knockdown HeLa  cells using the biological process category of the GO database. (e-h)  Graphic pie representations of the distribution of up- (e, f) and  down-regulated (g, h) genes (P < 0.05) in TIA-1 (e, g) or TIAR (f, h)  knockdown HeLa cells using the KEGG pathway database. In all  cases (a-h), percentages indicat the portion of total genes that are  associated with the biological functions and pathways shown. Click here for file Additional data file 7 Summary of GO and KEGG analyses of microarray-predicted genes  from TIA-1-depleted HeLa cells Analysis of KEGG pathways and GO terms corresponding to the  biological process category was applied to differentially expressed  genes in TIA-1 knockdown HeLa cells. Calculated P-values for each  pathway or category are shown. All analyses were performed using  Integromics™ software [39]. Click here for file Additional data file 8 Summary GO and KEGG analysis microarray-predicted genes from  TIAR-depleted HeLa cells Analysis of KEGG pathways and GO terms corresponding to the  biological process category was applied to differentially expressed  genes in TIAR knockdown HeLa cells. Calculated P-values for each  pathway or category are shown. All analyses were performed using  Integromics™ software [39]. Click here for file Additional data file 9 Global network of genes modulated upon TIA-1 and TIAR silencing Biochemical relationships between gene clusters up-regulated  (red) and down-regulated (green) as identified by microarray anal- yses were created using Pathway Studio software (version 6.0)  from Ariadne Genomics [40]. Click here for file Additional data file 10 List of up- and down-regulated genes upon TIA-1/TIAR silencing  that function as transcription and/or cell-cycle modulators Summary of differentially expressed genes in TIA-1 and TIAR- depleted HeLa cells that function as transcription and/or cell cycle  regulators. The set of studied gene parameters are as follow. Gene  Symbol: acronym of each gene. Gene Title: gene name. Fold  Change: mean value of fold change for each gene between control  and TIA-1 and TIAR-depleted HeLa cells. GO Biological Process:  accession number and description of the assigned GO in the biolog- ical process category [47]. Functions: summary of the more impor- tant roles associated with the list of transcription and/or cell-cycle- related genes. Click here for file Additional data file 11 List of primer pair sequences used to validate microarray-predicted  genes by real-time PCR analysis The primer sequences were designed using the Universal  ProbeLibrary Assay Design Center software from Roche [50] and  yielded only one amplified product using a BLAST search [51]. The  analyzed genes were: APPBP2, Amyloid beta precursor protein  binding protein 2; AREG, Amphiregulin; -actin, Actin, beta;  CD24, CD24 molecule; CXCL1, Chemokine (C-X-C motif) ligand 1;  CXCL2, Chemokine (C-X-C motif) ligand 2; EREG, Epiregulin;  FASTK, Fas-activated serine/threonine kinase; GDF15, Growth dif- ferentiation factor 15; IL-1A, Interleukin 1, alpha; IL-6, Interleukin  6; IL-8, Interleukin 8; KYNU, Kynureninase (L-kynurenine hydro- lase); MMP2, Matrix metallopeptidase 2; MTFR1, Mitochondrial  fission regulator 1; OPN1, Opsin 1 short-wave-sensitive; PAK3, p21  protein (Cdc42/Rac)-activated kinase 3; PTGS2, Prostaglandin- endoperoxide synthase 2; RAB40B, RAB40B, member of the RAS  oncogene family; TFDP2, Transcription factor Dp-2; TIA-1, T-cell  intracellular antigen 1; TIAR, TIA-1 related protein; TIMP2, TIMP  metallopeptidase inhibitor 2; TMSL8, Thymosin like-8; TNFSF10,  Tumor necrosis factor superfamily, member 10; and UCP2, Mito- chondrial uncoupling protein 2. Click here for file
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